CAS 10538-55-3
:méthyle (4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-diméthyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrène-17-yl]pentanoate
- 5β-Cholan-24-oic acid, 3α,7β-dihydroxy-, methyl ester
- 5β-Cholanic acid, 3α,7β-dihydroxy-, methyl ester
- Cholan-24-oic acid, 3,7-dihydroxy-, methyl ester, (3α,5β,7β)-
- Deoxyursocholic acid methyl ester
- Methyl 3α,7β-dihydroxy-5β-cholanoate
- Methyl ursodeoxycholate
- Ursodeoxycholic acid methyl ester
Ursodeoxycholic Acid EP Impurity G (Chenodeoxycholic Acid EP Impurity G)
CAS :Formule :C25H42O4Couleur et forme :White To Off-White SolidMasse moléculaire :406.61Methyl 3?,7?-Dihydroxy-5?-cholan-24-oate
CAS :Produit contrôléFormule :C25H42O4Couleur et forme :NeatMasse moléculaire :406.60Ursodeoxycholic Acid Methyl Ester
CAS :Formule :C25H42O4Couleur et forme :NeatMasse moléculaire :406.6Ursodeoxycholic acid methyl ester
CAS :Produit contrôléUrsodeoxycholic acid methyl ester is a bile acid that is produced from ursodeoxycholic acid. It is used as a drug to dissolve gallstones and reduce the risk of recurrent gallstones in patients who have had a cholecystectomy. Ursodeoxycholic acid methyl ester also reduces cholesterol levels by preventing its reabsorption in the small intestine and enhancing its excretion in the bile. This agent has been shown to modulate cell proliferation and differentiation, especially in cerebral tissue and muscle cells. Ursodeoxycholic acid methyl ester can be synthesized from ursodeoxycholic acid by saponification with base followed by methylation with methanol. The synthesis of this agent involves an elimination reaction between c1-c3 alcohols, which leads to impurities such as formaldehyde, acetone, glycerol, acetic acid, and butyric acid.
Formule :C25H42O4Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :406.6 g/mol




